Research | OneLook Acronym Finder |
Serial Number | 79353264 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2022-09-07 | Application Filed |
2022-10-20 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2022-10-20 | Status: Live/Pending |
2022-10-21 | Transaction Date |
Owner: | SEEGENE, INC. |
Address | 8FL, 9FL., Taewon Bldg., 91, Ogeum-ro, Songpa-gu Seoul KR |
Legal Entity Type | Corporation |
Legal Entity State | KR |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0101 | Medical examination tables; instrument tables for medical purposes; medical tables consisting of robotic arms; medical apparatus and instruments for amplifying nucleic acid; real-time gene amplification equipment for medical purposes; medical apparatus and instruments for extracting and purifying nucleic acid; medical automated apparatus and instruments for extracting and purifying nucleic acid for medical purposes; medical automated apparatus and instruments including real-time gene amplification equipment for medical purposes; medical automated apparatus and instruments including real-time gene amplification equipment and tables for medical purposes; automatic analyzers for medical diagnosis; automated analyzers for body fluids for medical purposes; automated analyzers for specimens for medical purposes |
GS0101 | Medical examination tables; instrument tables for medical purposes, namely, tables specially adapted for holding medical instruments; medical robots, namely, tables containing robotic arms for transporting clinical sample obtained from patients; medical diagnostic apparatus and instruments, namely, tables containing robotic arms for transporting clinical sample obtained from patients; medical diagnostic apparatus and instruments for amplifying nucleic acid; medical diagnostic apparatus for real-time gene amplification for medical purposes; medical diagnostic apparatus and instruments for extracting and purifying nucleic acid; medical diagnostic automated apparatus and instruments for extracting and purifying nucleic acid for medical purposes; medical diagnostic automated apparatus and instruments for real-time gene amplification for medical purposes; medical diagnostic automated apparatus and instruments, namely, tables containing real-time gene amplification apparatus for medical purposes; automatic analyzers of bodily protein content, blood, and immunofluorescene for medical diagnosis; automated analyzers for body fluids for medical purposes |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-10-20 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-10-21 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2022-10-25 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2022-12-07 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2022-12-12 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-12-13 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2023-02-09 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-02-09 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2023-03-07 | 9 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-04-12 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-04-12 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-04-13 | 12 TEME I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-04-17 | 13 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-04-17 | 14 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-04-17 | 15 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2023-05-18 | 16 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2023-05-18 | 17 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2023-05-18 | 18 GNFN O:Outgoing Correspondence |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-06-14 | 19 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-06-14 | 20 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-06-15 | 21 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-06-23 | 22 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-07-12 | 23 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2023-08-01 | 24 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-08-01 | 25 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2023-10-17 | 26 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-10-17 | 27 NRCC E:E-Mail |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-01-17 | 28 FICR P: |
FINAL DISPOSITION PROCESSED | 2024-01-19 | 29 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2024-01-19 | 30 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2024-02-14 | 31 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.